Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03323151
Title A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma (PrE0404)
Acronym PrE0404
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PrECOG, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Winship Cancer Institute of Emory University Atlanta Georgia 30322 United States Details
Georgia Cancer Center at Augusta University Augusta Georgia 30912 United States Details
Carle Cancer Center Urbana Illinois 61801 United States Details
University of Kansas Overland Park Kansas 66210 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU New York New York 10016 United States Details
University of Pennsylvania Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
West Virginia University Morgantown West Virginia 26506 United States Details
Gundersen Health System La Crosse Wisconsin 54601 United States Details
University of Wisconsin Madison Wisconsin 53792 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
ProHealth Care Waukesha Wisconsin 53188 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field